Article
Co-repression of <i>Yap1</i> and <i>Sox9</i> Abrogates Established Cholangiocarcinoma by Eliminating Transcriptional Compensation
2026-02-02
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background/Aims</h4> Intrahepatic cholangiocarcinoma (iCCA) represents an unmet clinical need due to its increasing incidence, aggressive biology, and limited treatment options. The extremely low-response rates to current systemic regimens and the emergence of adaptive resistance to targeted therapies underscore the urgent need for alternative therapeutic strategies. Given that the lineage-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 85af9fb8-840d-5994-88c0-d958d3c0add9
- DOI
- 10.64898/2026.01.30.702953
